Observe Medical ASA: Invitation to business update and first quarter 2022 presentation
Oslo, 2 June 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical"or the "Company"), will release its first quarter results for 2022 on Friday, 3 June 2022. The presentation will be available on Newsweb and the Company’s website at 07:00 CET.
Following the release, CEO, Rune Nystad and CFO, Per Arne Nygård will host a brief business update at Haakon VIIs gate 2, starting at 08:30 CET. The live presentation will also be available via webcast at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20220603_1/
After the live event, the presentation and recording will be made available
under the Investor Relations section on the Company's website, https://observemedical.com/investor-relations/.
For further information, please contact:
Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
Per Arne Nygård, CFO of Observe Medical
Mobile: +47 411 04 345
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik (Norway), Gothenburg (Sweden), Oulu (Finland), and Seattle (the US). In addition, Observe Medical has a direct sale organization in the Nordics and a distributor network internationally.
Further information is available at www.observemedical.com.